Could be interpreted that fimavacc got caught up in AZ discussions hence data publication is deliberately delayed. Bear in mind that AZ is busy with the COVID-19 vaccine for which hundred of millions of vaccine are pre-ordered … infectious diseases are hot subjects now for obvious reasons and fimavacc can enhance efficacy of vaccines. Remember that PW said they are monitoring all opportunities presented by the COVID-19 situation. Getting connected to AZ coupled with AZ efforts in COVID-19 logically dictates that fimavacc will be brought up higher up in AZ. This is a golden opportunity for pci biotech in my humble opinion.
Still have 2 days in H-1. We ll see how this plays out, but I’m sure the board and management are capable of a breakthrough.
Otherwise a great post. Thanks